Malaria funding & resource utilization: The first decade of Roll Back Malaria

01 Mar 2010

RBM Progress and Impact Series

At the end of the first decade of the Roll Back Malaria Partnership, the global burden of malaria remains high, and disproportionately impacts young children and pregnant women living in sub-Saharan Africa. However, major progress is being made in many malaria-endemic countries. Investment in highly effective interventions including prevention (insecticide-treated mosquito nets [ITNs], indoor residual spraying [IRS] of insecticides, and intermittent preventive treatment in pregnancy [IPTp]); diagnosis (expanded use of microscopy and rapid diagnostic tests [RDTs]); and treatment with highly effective antimalarial regimens, particularly artemisinin-based combination therapy (ACT), is leading to demonstrable progress in a number of countries.